Long-term topical nitrogen mustard treatment does not induce pulmonary fibrosis in MF patients.
DOI:
https://doi.org/10.2340/00015555747273Abstract
Eleven patients with mycosis fungoides had X-ray examinations of their lungs before, during and after topical treatment with mechlorethamine. The mean number of treatments was 163, ranging from 28 to 300 treatments within a period of 1 to 13 years (mean 7.8 years). Each exposure to the skin of mechlorethamine was between 20 and 40 mg giving a cumulative dosage in the range from 1.120 mg to a maximum of 12.000 mg. We looked for potential lung damage from mechlorethamine vapours, such as fibrosis of the lungs, but found none. Thus, we conclude that topical treatment with mechlorethamine of patients with mycosis fungoides is not only an effective treatment, but also a safe therapy.Downloads
Download data is not yet available.
Downloads
Published
1994-01-01
How to Cite
Nielsen, M., Rasmussen, K., Knudsen, N., & Thestrup-Pedersen, K. (1994). Long-term topical nitrogen mustard treatment does not induce pulmonary fibrosis in MF patients. Acta Dermato-Venereologica, 74(1), 70–71. https://doi.org/10.2340/00015555747273
Issue
Section
Articles
License
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
